• Design pharmacogenomics implementation program for the health system patient population |
• Identify a physician champion and engage key stakeholders |
• Target the right patient population for preemptive testing |
• Preemptive testing reduced issues around TAT, but introduced challenges with patient identification and reimbursement |
• Engage and educate clinicians early and repeatedly throughout the implementation process |
• Partner with hospital informatics to create clinical decision support tools and solve ongoing EHR challenges |
• A designated person or team to respond to results improves efficiency of therapy changes |
• Integrate clinical pharmacists to ensure adherence to the implementation algorithm and appropriate follow-up |
• Provide ongoing education programs for all health care providers |
• Learn from published experiences of early implementers, domain expert groups (CPIC) |